International suppliers meet at Accord Fawdon to celebrate growing together in partnership
Accord Fawdon recently hosted a special event to celebrate its supplier partnerships.
Read MoreNewsroom
Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare
Taipei, Taiwan and Harrow, England, February 11, 2019 – An exclusive license agreement for the commercialisation of Foresee Pharmaceutical’s (6576.TWO) novel FP-001 program (leuprorelin depot), Leuprolide Mesylate Injectable Suspension (LMIS) ready-to-use subcutaneous depot formulations has been granted to Accord Healthcare.
Read MoreThe Falsified Medicines Directive – Sandra Lee’s interview published in Pharmacy Business – February 2019 edition
Sandra Lee, Managing Director of Operations, explains why FMD is important and how the industry is preparing.
Read MoreAccord celebrates the one-year anniversary of the Fawdon factory
The team at Accord Fawdon recently celebrated the factory’s one-year anniversary with cakes and reflections on the successes of the past year.
Read MoreAccord and other leading voices in the pharmaceutical and financial industry debate how to drive consistent and long-term growth
In November 2018, at the House of Lords, Accord partnered Generics bulletin to bring influential
Read MoreACCORD HEALTHCARE - THE MOST RECOGNISED COMPANY AT THE GLOBAL GENERICS & BIOSIMILAR AWARDS 2018
We are delighted to announce that Accord Healthcare was the most recognised company at the Global Generics & Biosimilar Awards 2018, having won awards for: Company of the Year and Biosimilar Initiative of the Year.
Read MoreAccord Healthcare’s (Intas) Pelgraz® (pegfilgrastim) Given Green Light by CHMP
Pelgraz - a pegylated G-CSF Biosimilar, is latest addition to Accord Healthcare's established portfolio of over 30 oncology treatments across Europe
Read MoreContinued growth in Europe
Over the past two weeks, we have continued to further our expansion in Europe with the opening of a new office in Basel, Switzerland and further expansion of operations in Austria.
Read MoreAccord Healthcare were honoured to be awarded the fastest growing Indian origin company in Britain awarded by Grant Thornton
The 'India Meets Britain Tracker 2018', released annually by Grant Thornton in collaboration with the Confederation of Indian Industry awards the fastest UK based companies of Indian origin.
Read MorePaweł Mazur, East Area Director of Accord, featured in the Pharma Boardroom and the HCLS Review report on Poland
As East Area Director for the vast CEE market, Paweł Mazur explains how Accord Healthcare Poland
Read More
